Nilotinib Impurity 1
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

Nilotinib Impurity 1

● In Stock

Catalogue No.:VE006045
CAS No.:N/A
Mol. Formula:C28H21ClF3N7O
Mol. Weight:563.96 g/mol

Additional information on Nilotinib Impurity 1

Parent drug

Nilotinib

IUPAC Name

3-(5-chloro-4-(pyridin-3-yl)pyrimidin-2-ylamino)-4-methyl-N-(3-(4- methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)benzamide

Synonyms

N/A

Smiles

Cc5cn(c4cc(NC(=O)c3ccc(C)c(Nc2ncc(Cl)c(c1cccnc1)n2)c3)cc(C(F)(F)F)c4)cn5

Description

It is an impurity present in Nilotinib which is a tyrosine kinase inhibitor approved for the treatment of chronic myelogenous leukemia and is used to treat chronic myeloid leukemia (CML) in people who have tested positive for the Philadelphia chromosome.

References

Gopireddy, Ramana Reddy, and Arthanareeswari Maruthapillai. “A Stability Indicating Method Development and Validation for Separation of Process Related Impurities and Characterization of Unknown Impurities of Tyrosine Kinase Inhibitor Nilotinib by RP-HPLC, NMR Spectroscopy and ESI-MS.” Materials Today: Proceedings, vol. 40, 2021, pp. S127–38, https://doi.org/10.1016/j.matpr.2020.03.837.? Kondra, S. B., et al. “A

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url